These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12132778)

  • 21. Candida glabrata fungaemia in intensive care units.
    Ruan SY; Lee LN; Jerng JS; Yu CJ; Hsueh PR
    Clin Microbiol Infect; 2008 Feb; 14(2):136-40. PubMed ID: 18042196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective study of fungaemia in a single cancer institution over a 10-y period: aetiology, risk factors, consumption of antifungals and outcome in 140 patients.
    Kovacicová G; Spánik S; Kunová A; Trupl J; Sabo A; Koren P; Sulcová M; Mateicka F; Novotný J; Pichnová E; Jurga L; Chmelík B; Obertik T; West D; Krcéry V
    Scand J Infect Dis; 2001; 33(5):367-74. PubMed ID: 11440223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome.
    Krcmery V; Oravcova E; Spanik S; Mrazova-Studena M; Trupl J; Kunova A; Stopkova-Grey K; Kukuckova E; Krupova I; Demitrovicova A; Kralovicova K
    J Antimicrob Chemother; 1998 Mar; 41(3):373-80. PubMed ID: 9578164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fungemia in non-HIV-infected patients: a five-year review.
    Anunnatsiri S; Chetchotisakd P; Mootsikapun P
    Int J Infect Dis; 2009 Jan; 13(1):90-6. PubMed ID: 18653367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.
    Pemán J; Cantón E; Quindós G; Eraso E; Alcoba J; Guinea J; Merino P; Ruiz-Pérez-de-Pipaon MT; Pérez-del-Molino L; Linares-Sicilia MJ; Marco F; García J; Roselló EM; Gómez-G-de-la-Pedrosa E; Borrell N; Porras A; Yagüe G;
    J Antimicrob Chemother; 2012 May; 67(5):1181-7. PubMed ID: 22351683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection.
    Sipsas NV; Lewis RE; Tarrand J; Hachem R; Rolston KV; Raad II; Kontoyiannis DP
    Cancer; 2009 Oct; 115(20):4745-52. PubMed ID: 19634156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
    Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Candidaemia in a London teaching hospital: analysis of 128 cases over a 7-year period.
    Schelenz S; Gransden WR
    Mycoses; 2003; 46(9-10):390-6. PubMed ID: 14622387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hematogenous infections due to Candida parapsilosis: changing trends in fungemic patients at a comprehensive cancer center during the last four decades.
    Safdar A; Perlin DS; Armstrong D
    Diagn Microbiol Infect Dis; 2002 Sep; 44(1):11-6. PubMed ID: 12376025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antifungal therapy for infants, children and adolescents with suspected or documented invasive fungal infection].
    Odio CM
    Drugs Today (Barc); 2010 Apr; 46 Suppl C():33-46. PubMed ID: 20490381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital.
    Bedini A; Venturelli C; Mussini C; Guaraldi G; Codeluppi M; Borghi V; Rumpianesi F; Barchiesi F; Esposito R
    Clin Microbiol Infect; 2006 Jan; 12(1):75-80. PubMed ID: 16460550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
    Krcmery V; Barnes AJ
    J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates.
    Roilides E; Farmaki E; Evdoridou J; Dotis J; Hatziioannidis E; Tsivitanidou M; Bibashi E; Filioti I; Sofianou D; Gil-Lamaignere C; Mueller FM; Kremenopoulos G
    Eur J Clin Microbiol Infect Dis; 2004 Oct; 23(10):745-50. PubMed ID: 15605181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Spectrum and risk factors of invasive fungal infection].
    Osorio JJ; Román AR; Torre-Cisneros J
    Enferm Infecc Microbiol Clin; 2007; 25(7):467-76. PubMed ID: 17692214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and microbiologic determinants of serious bloodstream infections in Egyptian pediatric cancer patients: a one-year study.
    El-Mahallawy H; Sidhom I; El-Din NH; Zamzam M; El-Lamie MM
    Int J Infect Dis; 2005 Jan; 9(1):43-51. PubMed ID: 15603994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Epidemiology of fungemia in a university hospital; therapeutic incidence].
    Pavese P; Brion JP; Lebeau B; Grillot R; Ambroise-Thomas P
    Pathol Biol (Paris); 1999 May; 47(5):579-83. PubMed ID: 10418046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Multicenter study of fungemia due to yeasts in Argentina].
    Rodero L; Davel G; Soria M; Vivot W; Córdoba S; Canteros CE; Saporiti A;
    Rev Argent Microbiol; 2005; 37(4):189-95. PubMed ID: 16502638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breakthrough fungaemia in neonates and infants caused by Candida albicans and Candida parapsilosis susceptible to fluconazole in vitro.
    Krcmery V; Huttova M; Mateicka F; Laho L; Jurga L; Ondrusova A; Tarekova Z; Kralinsky K; Hanzen J; Liskova A; Mrazova M; Sabo A; Pisarcikova M; Kovacicova G; Chovancova D; Szovenyiova Z
    J Antimicrob Chemother; 2001 Oct; 48(4):521-5. PubMed ID: 11581231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High incidence of Candida parapsilosis candidaemia in non-neutropenic critically ill patients: epidemiology and antifungal susceptibility.
    Dizbay M; Fidan I; Kalkanci A; Sari N; Yalcin B; Kustimur S; Arman D
    Scand J Infect Dis; 2010; 42(2):114-20. PubMed ID: 19883150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
    Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
    Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.